These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7886734)

  • 1. Clinical experience with excitatory amino acid antagonist drugs.
    Muir KW; Lees KR
    Stroke; 1995 Mar; 26(3):503-13. PubMed ID: 7886734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerestat and other NMDA antagonists in ischemic stroke.
    Lees KR
    Neurology; 1997 Nov; 49(5 Suppl 4):S66-9. PubMed ID: 9371155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
    Ikonomidou C; Turski L
    Lancet Neurol; 2002 Oct; 1(6):383-6. PubMed ID: 12849400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate antagonists for stroke and head trauma.
    Wood PL; Hawkinson JE
    Expert Opin Investig Drugs; 1997 Apr; 6(4):389-97. PubMed ID: 15989606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate AMPA receptor antagonist treatment for ischaemic stroke.
    Akins PT; Atkinson RP
    Curr Med Res Opin; 2002; 18 Suppl 2():s9-13. PubMed ID: 12365832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory amino acid antagonists for acute stroke.
    Muir KW; Lees KR
    Cochrane Database Syst Rev; 2003; 2003(3):CD001244. PubMed ID: 12917902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor antagonists and glycine site NMDA antagonists.
    Madden K
    Curr Med Res Opin; 2002; 18 Suppl 2():s27-31. PubMed ID: 12365826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.
    Wang CX; Shuaib A
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):143-51. PubMed ID: 15857299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise and fall of NMDA antagonists for ischemic stroke.
    Hoyte L; Barber PA; Buchan AM; Hill MD
    Curr Mol Med; 2004 Mar; 4(2):131-6. PubMed ID: 15032709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.
    Jansen M; Dannhardt G
    Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia.
    Chen J; Graham SH; Simon RP
    Brain Res; 1995 Nov; 699(1):121-4. PubMed ID: 8616600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.
    Planells-Cases R; Montoliu C; Humet M; Fernández AM; García-Martínez C; Valera E; Merino JM; Pérez-Payá E; Messeguer A; Felipo V; Ferrer-Montiel A
    J Pharmacol Exp Ther; 2002 Jul; 302(1):163-73. PubMed ID: 12065713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of non-competitive N-methyl-D-aspartate receptor antagonism on cerebral oedema and cerebral infarct size in the aging ischaemic brain.
    Davis M; Perry RH; Mendelow AD
    Acta Neurochir Suppl; 1997; 70():30-3. PubMed ID: 9416269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke.
    Yu G; Wu F; Wang ES
    Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.